The antihypertensive therapy with the cardioselective beta-receptor an
tagonist talinolol is effective and safe in patients with mild to mode
rate hypertension, An increase of the talinolol dosage was not associa
ted with an increase of side effects or study interruptions, In more t
han 90% of the patients a one daily dose of 100 mg talinolol was suffi
cient. The profitable metabolic characteristics of talinolol especiall
y concerning the lipid metabolism, are to be pointed out advantageous
regarding the development of coronary heart disease.